WKN: | A3E5EG |
ISIN: | DE000A3E5EG5 |
Land: | Deutschland |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
EQS-News: ABIVAX / Key word(s): Conference Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 ...weiterlesen